Last reviewed · How we verify

NCT05376917: ELVIRA4

Quality of Life Evaluation After Cataract Surgery Using 4 Types of Intraocular Lens Implant Combinations

Completed NA Last updated 28 May 2025
What this trial tests

NA trial testing Zeiss CT Asphina / Zeiss CT Asphina in Cataract in 200 participants. Completed in 21 May 2025.

Timeline
30 January 2023
Primary endpoint
21 May 2025
21 May 2025

Quick facts

Lead sponsorCentre Hospitalier Régional Metz-Thionville
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment200
Start date30 January 2023
Primary completion21 May 2025
Estimated completion21 May 2025
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Régional Metz-Thionville

Who can join

18 and older, any sex, with Cataract or Intraocular Lens Implant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is multicenter, prospective, comparative and randomized study focusing on the evolution of the quality of Life and Uncorrected Binocular Visual Acuity (UBVA) evaluation at 3 months after cataract surgery in patients who underwent 4 different types of intraocular lens Implant (IOL) combinations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cataract

Currently open trials in the same condition.

Other Centre Hospitalier Régional Metz-Thionville trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05376917.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing